[STJ] St Jude Medical Inc

Symbol: STJ Last Price: 45.98 Change: +0.17 (+0.37%) Website: click here

Headlines for [STJ]

• STJ 8/20/2008 08:00am
  St Jude Medical Inc FDA approves Arecibo manufacturing plant- The new plant will expand the company's cardiac rhythm management manufacturing capacity and is expected to create at least 1,250 new jobs within the next more...
  
• STJ 8/18/2008 01:01pm
  St Jude Medical Inc Receives CE Mark approval and FDA clearance for HIFU surgical ablation products- The Epicor LP Cardiac Ablation System is a second generation technology that uses HIFU (high intensity focused more...
  
• STJ 8/13/2008 08:00am
  St Jude Medical Inc Receives U.S. and European Approvals of EonC- EonC is the First Extended-Life Primary Cell Neurostimulator for the Treatment of Chronic Pain. - The EonC neurostimulator provides a convenient option more...
  
• STJ 8/12/2008 07:25am
  St Jude Medical Inc Canaccord Adams Initiates STJ with Hold, price target: $50
  
• STJ 7/24/2008 06:05pm
  St Jude Medical Inc Piper Jaffray Initiates STJ with Neutral
  

Healthcare sector headlines

• NVO Today 02:53pm
  Novo Nordisk A/S FDA discloses approval for NovoLog Mix 50/50 (insulin aspart protamine and insulin aspart) Injectable Suspension
  
• BRL Today 12:19pm
  Barr Pharmaceuticals Inc Subsidiary receives approval for generic version of Razadyne tablets- Co. received final approval from the U.S. FDA to manufacture and market a generic version of Ortho McNeil Janssen's Razadyne, 4 more...
  
• THR.BE Today 12:07pm
  ThromboGenics Reports H108 Rev €30.3M; Appoints Dr. Patrik De Haes CEO- As of June 30, 2008, ThromboGenics had €40.4M in cash and cash equivalents. - Co. expects to see an increase in its operating expenses in more...
  
• HITK Today 11:54am
  Hi-Tech Pharmacal Update: Files suit to confirm market exclusivity status regarding Dorzolamide and Timolol Ophthalmic Solution- Note: dorzolamide and timolol ophthalmic solution is the generic for Merck's Cosopt
  
• ELN Today 11:41am
  Elan Corp PLC Morgan Stanley Initiates ELN with Overweight (timing uncertain)- price target €12